In addition, high levels of CD3 but low levels of FoxP3 and L1CAM in tumor cells tended to correlate with improved patient survival, being in line with previous reports demonstrating high tumor-associated expression of FoxP3 and L1CAM as negative prognostic marker [21], [24]. This evidence concerns the gene FOXP3 and neoplasm.